Pipeline Overview
Zalicus Pipeline
The Zalicus internal development pipeline is focused on pain and includes Z160, which is in Phase 2 development for neuropathic pain, Z944, which is in Phase 1 development for pain, and our pre-clinical Ion channel program, which is advancing lead candidates for potential clinical development in pain. Zalicus also has partnered programs in other therapeutic areas.